socio-economic benefits

R&D

It has been estimated that 12% of the UK population suffer from irritable bowel syndrome (IBS), an umbrella term that describes a bro

News

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.